Chief Scientific Officer & Co-Founder
Dr. Marvin S. Hausman, MD
Co-authored the 2026 Fragile X rat study in Neuropsychopharmacology. Immunologist, board-certified urological surgeon, former U.S. Public Health Service Surgeon at the NIH, and pharmaceutical developer with over 35 years in CNS and clinical drug development.